Clinical trial
Radiation Therapy in Treating Patients With Bile Duct, Gallbladder, or…
NCT00003411 · University of Pittsburgh, Other · Completed
Key facts
| NCT number | NCT00003411 |
|---|---|
| Title | Radiation Therapy in Treating Patients With Bile Duct, Gallbladder, or Pancreatic Cancer |
| Official title | Phase I Dose Escalation and Pharmacokinetics Study of the Radiosensitizer, Gadolinium Texaphyrin (Gd-Tex, NSC 695238) With Concurrent Radiotherapy in Advanced Biliary Tree and Pancreatic Cancers |
| Lead sponsor | University of Pittsburgh, Other |
| Collaborators | National Cancer Institute (NCI) NIH |
| Status | Completed |
| Phase | Phase 1 |
| Study type | Interventional |
| Conditions | Extrahepatic Bile Duct Cancer, Gallbladder Cancer, Pancreatic Cancer |
| Intervention type | Drug, Radiation |
| Interventions | motexafin gadolinium, radiation therapy |
| Start date | Nov 1, 1998 |
| Primary completion | Jun 1, 2002 |
| Completion | Jun 1, 2002 |
| First posted | Feb 20, 2004 |
| Last update posted | Jan 18, 2016 |
| Countries | United States |
At a glance
- 1–9 Study sites
- No Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: